Rare diseases
Investigational molecules
Locations
Back to Belgium1 clinical trial in Haaltert, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focusing on SARS-CoV-2 immunity patterns in various population groups, particularly examining antibody responses in immunocompromised individuals.
This longitudinal study encompasses multiple patient groups including transplant recipients, dialysis patients, and nursing home residents, providing valuable insights into COVID-19 immunity in vulnerable populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
